These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 34650444)
1. Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension. Xu Q; Zhuo K; Cai R; Su X; Zhang L; Liu Y; Zhu L; Ren F; Zhou MS Front Physiol; 2021; 12():732084. PubMed ID: 34650444 [TBL] [Abstract][Full Text] [Related]
2. The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling. Xu Q; Zhuo K; Zhang X; Zhen Y; Liu L; Zhang L; Gu Y; Jia H; Chen Q; Liu M; Dong J; Zhou MS Eur J Pharmacol; 2024 Jan; 962():176252. PubMed ID: 38061470 [TBL] [Abstract][Full Text] [Related]
3. The regulation of yes-associated protein/transcriptional coactivator with PDZ-binding motif and their roles in vascular endothelium. Zhang W; Li QQ; Gao HY; Wang YC; Cheng M; Wang YX Front Cardiovasc Med; 2022; 9():925254. PubMed ID: 35935626 [TBL] [Abstract][Full Text] [Related]
4. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis. Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657 [TBL] [Abstract][Full Text] [Related]
5. Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling. Wu P; Liu Z; Zhao T; Xia F; Gong L; Zheng Z; Chen Z; Yang T; Duan Q Biochem Biophys Res Commun; 2019 May; 512(4):736-741. PubMed ID: 30926167 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice. Zhang J; Xu Q; Ren F; Liu Y; Cai R; Yao Y; Zhou MS Can J Physiol Pharmacol; 2021 Oct; 99(10):1000-1006. PubMed ID: 33852804 [TBL] [Abstract][Full Text] [Related]
7. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury. Konishi T; Schuster RM; Lentsch AB Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389 [TBL] [Abstract][Full Text] [Related]
8. Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) mediate cell density-dependent proinflammatory responses. Zhang Q; Han X; Chen J; Xie X; Xu J; Zhao Y; Shen J; Hu L; Xu P; Song H; Zhang L; Zhao B; Wang YJ; Xia Z J Biol Chem; 2018 Nov; 293(47):18071-18085. PubMed ID: 30315101 [TBL] [Abstract][Full Text] [Related]
9. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis. Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452 [TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ: a promising target for squamous cell carcinoma treatment. Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model. Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764 [TBL] [Abstract][Full Text] [Related]
12. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ). Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650 [TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer. Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404 [TBL] [Abstract][Full Text] [Related]
14. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway. Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081 [TBL] [Abstract][Full Text] [Related]
15. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy. Juan WC; Hong W Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805 [TBL] [Abstract][Full Text] [Related]
16. Relationship between Keloid Formation and YAP/TAZ Signaling. Aramaki-Hattori N; Okabe K; Hamada M; Takato T; Kishi K Plast Reconstr Surg Glob Open; 2017 Jun; 5(6):e1357. PubMed ID: 28740772 [TBL] [Abstract][Full Text] [Related]
17. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases. Yu Y; Su X; Qin Q; Hou Y; Zhang X; Zhang H; Jia M; Chen Y Pharmacol Res; 2020 Sep; 159():105009. PubMed ID: 32553712 [TBL] [Abstract][Full Text] [Related]
18. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
19. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury. Deng F; Wu Z; Zou F; Wang S; Wang X Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987 [TBL] [Abstract][Full Text] [Related]
20. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Wang L; Luo JY; Li B; Tian XY; Chen LJ; Huang Y; Liu J; Deng D; Lau CW; Wan S; Ai D; Mak KK; Tong KK; Kwan KM; Wang N; Chiu JJ; Zhu Y; Huang Y Nature; 2016 Dec; 540(7634):579-582. PubMed ID: 27926730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]